240 related articles for article (PubMed ID: 15609382)
1. Impact of a surgical training programme on rectal cancer outcomes in Stockholm.
Martling A; Holm T; Rutqvist LE; Johansson H; Moran BJ; Heald RJ; Cedermark B
Br J Surg; 2005 Feb; 92(2):225-9. PubMed ID: 15609382
[TBL] [Abstract][Full Text] [Related]
2. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer.
Martling A; Cedermark B; Johansson H; Rutqvist LE; Holm T
Br J Surg; 2002 Aug; 89(8):1008-13. PubMed ID: 12153626
[TBL] [Abstract][Full Text] [Related]
3. [Improved therapeutic results in rectal cancer. Preoperative radiotherapy and continuing education of the surgeons is efficient].
Holm T; Cedermark B; Johansson H; Singnomklao T; Rutqvist LE
Lakartidningen; 2000 Aug; 97(34):3582-6. PubMed ID: 11036377
[TBL] [Abstract][Full Text] [Related]
4. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
Kapiteijn E; Putter H; van de Velde CJ;
Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
[TBL] [Abstract][Full Text] [Related]
5. Impact of radiotherapy on local recurrence of rectal cancer in Norway.
Hansen MH; Kjaeve J; Revhaug A; Eriksen MT; Wibe A; Vonen B;
Br J Surg; 2007 Jan; 94(1):113-8. PubMed ID: 17083107
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcomes after total mesorectal excision for rectal cancer.
Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
[TBL] [Abstract][Full Text] [Related]
7. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; Schrag D; Ayanian JZ; O'Connell MJ; Weeks JC; Mayer RJ; Willett CG; MacDonald JS; Benson AB; Fuchs CS
J Clin Oncol; 2004 Jan; 22(1):166-74. PubMed ID: 14701779
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. Recurrence and survival after mesorectal excision for rectal cancer.
Bülow S; Christensen IJ; Harling H; Kronborg O; Fenger C; Nielsen HJ; ;
Br J Surg; 2003 Aug; 90(8):974-80. PubMed ID: 12905551
[TBL] [Abstract][Full Text] [Related]
10. Experience of surgery for rectal cancer with total mesorectal excision in a general surgical practice.
Dowdall JF; Maguire D; McAnena OJ
Br J Surg; 2002 Aug; 89(8):1014-9. PubMed ID: 12153627
[TBL] [Abstract][Full Text] [Related]
11. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
12. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
13. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery.
Maurer CA; Z'Graggen K; Renzulli P; Schilling MK; Netzer P; Büchler MW
Br J Surg; 2001 Nov; 88(11):1501-5. PubMed ID: 11683749
[TBL] [Abstract][Full Text] [Related]
14. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
[TBL] [Abstract][Full Text] [Related]
16. [Skills by training. Education and case volume are strong prognostic factors in rectal cancer surgery].
Martling A; Holm T; Cedermark B
Lakartidningen; 2005 Feb 7-13; 102(6):374-6. PubMed ID: 15754678
[TBL] [Abstract][Full Text] [Related]
17. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
18. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
[TBL] [Abstract][Full Text] [Related]
19. Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer.
Holm T; Johansson H; Rutqvist LE; Cedermark B
Br J Surg; 2001 Jun; 88(6):839-43. PubMed ID: 11412255
[TBL] [Abstract][Full Text] [Related]
20. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy.
Holm T; Johansson H; Cedermark B; Ekelund G; Rutqvist LE
Br J Surg; 1997 May; 84(5):657-63. PubMed ID: 9171755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
